// App-Quantinova.ai

: Overcoming miR-106a induced radioresistance in prostate cancer: Targeting senescence with KU-55933.

Researchers

Presenter

  • Christianne Hoey

Principal Investigators

  • Jessica Ray

  • Xiaoyong Huang

  • Jouhyun Jeon

  • Paul Christopher Boutros

  • Stanley K. Liu

Medical Centers

  • University of Toronto, Toronto, ON, Canada

  • University of Toronto, Toronto, ON, Canada

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • KU-55933

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved